What You Should Know
- Abridge announced that partner health systems can now deploy its clinical intelligence agent enterprise-wide to every clinician, regardless of whether they currently use ambient documentation.
- The agent delivers context-aware clinical decision support (CDS) embedded directly inside native EHR interfaces or accessible via a companion mobile and web experience connected to the patient chart.
- Across more than 300 enterprise health systems, monthly active users of Abridge’s CDS features now exceed 50% of eligible clinicians, with average queries per clinician tripling over the last two months.
- The tool addresses the risks of unapproved “shadow AI” by routing clinical inquiries through the health system’s existing, vetted security, governance, and longitudinal data pipelines.
- Key platform capabilities include pre-visit chart summaries, pre-filled medical calculators, evidence-grounded literature retrieval (NEJM, JAMA, ADA, UpToDate), automated referral letters, and the ability for physicians to earn AMA PRA Category 1 Credit™.
Eliminating Point-of-Care “Shadow AI”
As frontline clinicians encounter complex multi-condition presentations and drug interactions, many turn to consumer chatbots or generic web searches. These ad-hoc lookups introduce protected health information (PHI) leak risks, pull generic answers stripped of patient context, and add interface friction.
Abridge addresses this by running its intelligence agent on the health system’s existing enterprise deployment, security agreements, and EHR data pipelines:
- Enterprise-Wide Provisioning: Enables health systems to activate chart-connected decision support across entire medical staffs—including subspecialists and inpatient teams—without requiring separate IT security reviews or clinician-by-clinician software licensing.
- Pre-Visit & In-Workflow Chart Synthesis: Generates concise pre-visit briefs highlighting interval health changes since the last encounter and automatically pre-populates complex medical calculators using discrete EHR parameters.
- Evidence-Grounded Querying: Connects real-time patient charts to authoritative medical repositories, including The New England Journal of Medicine, JAMA Network, American Diabetes Association, American Academy of Family Physicians, Neurology, Journal of Clinical Oncology, and Wolters Kluwer’s UpToDate.
- Downstream Workflow Execution & CME: Automates contextualized referral letters and handoff summaries while allowing clinicians to earn AMA PRA Category 1 Credit™ for point-of-care inquiries.
Scale and Organic Frontline Adoption
Deployed across more than 300 enterprise health systems, monthly active users have expanded to over half of eligible Abridge clinicians, with per-clinician query volumes tripling within two months of rollout. At UPMC, more than 60% of active users adopted the intelligence agent organically without dedicated training campaigns.
“Adoption of decision support has outpaced anything we’ve shipped before because it feels like a natural extension of Abridge. It understands the context of the patient in front of the clinician, it’s grounded in the evidence they already trust, and it connects to what they want to do next,” said Dr. Shiv Rao, CEO and Co-Founder of Abridge. “Our partners asked us to put that experience in the hands of their entire care team: clinical intelligence that is loved by users, embraced by leaders, and ready for every clinician at an Abridge health system.”
